| 52.36 Data as of Jun 17 |  +0.31 / +0.60%Today’s Change | 41.41 Today|||52-Week Range 58.41 | +6.16% Year-to-Date |
| 5 Stocks Raising The Drugs Industry Higher Jun 17 / TheStreet.com | Ovarian Cancer Drug Half Way There Jun 13 / MotleyFool.com |
| Eli Lilly to Take Over Development of Diabetes Drug Jun 17 / MotleyFool.com | Is This Healthcare Company a Strong Investment? Jun 13 / MotleyFool.com |
| Positive Data on Incyte/LLY's Baricitinib - Analyst Blog Jun 14 / Zacks.com | CHMP Positive on Sanofi's Lantus - Analyst Blog Jun 11 / Zacks.com |
| Cramer's 6 Stocks in 60 Seconds: GME LLY RBCN AXP HRL CLH (Update 1) Jun 14 / TheStreet.com | Apricus' Vitaros Approved in Europe - Analyst Blog Jun 11 / Zacks.com |
| Lilly Alzheimer's Study Terminated - Analyst Blog Jun 14 / Zacks.com | Is Pfizer a Buy? Jun 11 / MotleyFool.com |
| Previous close | 52.05 |
| Today’s open | 52.42 |
| Day’s range | 52.20 - 53.05 |
| Volume | 5,135,100 |
| Average volume (3 months) | 4,979,380 |
| Market cap | $59.0B |
| Dividend yield | 3.74% |
| Earnings growth (last year) | -6.15% |
| Earnings growth (this year) | +15.83% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | -6.93% |
| P/E ratio | 12.6 |
| Price/Sales | 2.43 |
| Price/Book | 4.06 |
| Today’s change | Today’s % change | |
|---|---|---|
| ABTAbbott Laboratories | +0.08 | +0.22% |
| AZNAstraZeneca PLC | +0.17 | +0.33% |
| ABBVAbbVie Inc | -0.20 | -0.46% |
| CELGCelgene Corp | -1.66 | -1.39% |
| Next reporting date | July 24, 2013 |
| EPS forecast (this quarter) | $1.00 |
| Annual revenue (last year) | $22.6B |
| Annual profit (last year) | $4.1B |
| Net profit margin | 18.09% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chief Executive Officer, CFO & EVP-Global Services Derica W. Rice, MBA |
Vice President- Biotechnology Discovery Research Thomas F. Bumol, PhD |
Corporate headquarters Indianapolis, Indiana |
.
